Excerpt from: Cincinnati Children's Blog (click for full article)
A multi-center program hopes to provide a roadmap for preventing early cystic fibrosis (CF) lung disease in infants and young children. Researchers, including Dr. John Clancy from Cincinnati Children’s, plan to study pre-symptomatic lung disease in children with CF under a new grant program of the National Heart, Lung and Blood Institute (NHLBI).
Results could reveal how CF develops, which in turn could lead to interventions that delay or prevent disease progression. The studies also could provide critical information to help resolve competing theories on the origin and progression of CF-associated abnormalities.